"Gastrins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.
| Descriptor ID |
D005755
|
| MeSH Number(s) |
D06.472.317.413 D06.472.699.280 D12.644.400.320 D12.644.548.280 D12.776.631.650.320
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gastrins".
Below are MeSH descriptors whose meaning is more specific than "Gastrins".
This graph shows the total number of publications written about "Gastrins" by people in this website by year, and whether "Gastrins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastrins" by people in Profiles.
-
Gaudreau MC, Gudi RR, Li G, Johnson BM, Vasu C. Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes. Autoimmunity. 2022 03; 55(2):95-108.
-
Rogers LM, Boy E, Miller JW, Green R, Rodriguez M, Chew F, Allen LH. Predictors of cobalamin deficiency in Guatemalan school children: diet, Helicobacter pylori, or bacterial overgrowth? J Pediatr Gastroenterol Nutr. 2003 Jan; 36(1):27-36.
-
Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Am J Gastroenterol. 1997 Mar; 92(3):429-37.
-
Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol. 1996 Sep; 91(9):1749-57.
-
Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996 Aug; 91(8):1532-8.
-
Lacy ER, Cowart KS, King JS, DelValle J, Smolka AJ. Epithelial response of the rat gastric mucosa to chronic superficial injury. Yale J Biol Med. 1996 Mar-Apr; 69(2):105-18.
-
Gideon RM, Paoletti V, Castell DO. Omeprazole, serum gastrin, and gastric acid suppression. Ann Intern Med. 1995 Feb 01; 122(3):237-8.
-
Burman P, Kämpe O, Kraaz W, Lööf L, Smolka A, Karlsson A, Karlsson-Parra A. A study of autoimmune gastritis in the postpartum period and at a 5-year follow-up. Gastroenterology. 1992 Sep; 103(3):934-42.
-
Chew CS, Ljungström M, Smolka A, Brown MR. Primary culture of secretagogue-responsive parietal cells from rabbit gastric mucosa. Am J Physiol. 1989 Jan; 256(1 Pt 1):G254-63.
-
Richter JE, Pandol SJ, Castell DO, McCarthy DM. Gastroesophageal reflux disease in the Zollinger-Ellison syndrome. Ann Intern Med. 1981 Jul; 95(1):37-43.